{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:07:35Z","timestamp":1791191255382,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":2580,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1111\/ajt.13347","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T10:00:38Z","timestamp":1434708038000},"page":"2921-2930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":340,"title":["Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific Antibody"],"prefix":"10.1016","volume":"15","author":[{"given":"C.","family":"Wiebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.W.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.D.","family":"Blydt-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pochinco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Birk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Karpinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Storsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.W.","family":"Nickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.13347_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1600-6143.2011.03525.x","article-title":"Summary of FDA antibody-mediated rejection workshop","volume":"11","author":"Archdeacon","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13347_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff \u201909 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib5","unstructured":"Rosner A. Fundamentals of biostatistics. 6th ed. Belmont, CA: Thomson-Brooks\/Cole; 2006e."},{"key":"10.1111\/ajt.13347_bib6","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching\u2014A strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib7","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1600-6143.2005.00853.x","article-title":"Long-Term deterioration of kidney allograft function","volume":"5","author":"Kasiske","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/geronj\/31.2.155","article-title":"The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study","volume":"31","author":"Rowe","year":"1976","journal-title":"J Gerontol"},{"key":"10.1111\/ajt.13347_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1053\/j.ajkd.2014.09.006","article-title":"GFR decline as an end point in trials of CKD: A viewpoint from the FDA","volume":"64","author":"Thompson","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.13347_bib10","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"key":"10.1111\/ajt.13347_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/TP.0000000000000148","article-title":"Predictive patterns of early medication adherence in renal transplantation","volume":"98","author":"Nevins","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13347_bib12","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/ki.2013.465","article-title":"Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure","volume":"85","author":"Sapir-Pichhadze","year":"2014","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13347_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.transproceed.2007.02.074","article-title":"Medication adherence in chronic disease: Issues in posttransplant immunosuppression","volume":"39","author":"Hansen","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.13347_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00007890-199502000-00006","article-title":"Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients","volume":"59","author":"De Geest","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13347_bib15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1126\/science.346.6207.288","article-title":"Nonadherence: A bitter pill for drug trials","volume":"346","author":"Servick","year":"2014","journal-title":"Science"},{"key":"10.1111\/ajt.13347_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00007890-198808000-00007","article-title":"Early function as the principal correlate of graft survival","volume":"46","author":"Halloran","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13347_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13347_bib18","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/ndt\/gfl042","article-title":"Major effects of delayed graft function and cold ischaemia time on renal allograft survival","volume":"21","author":"Quiroga","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.13347_bib19","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1600-6143.2011.03754.x","article-title":"Delayed graft function in the kidney transplant","volume":"11","author":"Siedlecki","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0002-9440(10)65598-8","article-title":"Ischemia\/reperfusion injury in human kidney transplantation: An immunohistochemical analysis of changes after reperfusion","volume":"153","author":"Koo","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1111\/ajt.13347_bib21","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1172\/JCI74370","article-title":"Non-self recognition by monocytes initiates allograft rejection","volume":"124","author":"Oberbarnscheidt","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1111\/ajt.13347_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-hla antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13347_bib23","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/TP.0000000000000190","article-title":"Changes in successive measures of de novo donor-specific anti-human leukocyte antigen antibodies intensity and the development of allograft dysfunction","volume":"98","author":"Dieplinger","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13347_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: Inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib26","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/j.1600-6143.2007.01995.x","article-title":"Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies","volume":"7","author":"Wavamunno","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib27","doi-asserted-by":"crossref","unstructured":"Halloran PF, Chang J, Famulski K, et al. Disappearance of T cell\u2013mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients. J Am Soc Nephrol 2014; Epub ahead of print.","DOI":"10.1681\/ASN.2014060588"},{"key":"10.1111\/ajt.13347_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","article-title":"Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies","volume":"13","author":"de Kort","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","article-title":"Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated t-cell depletion","volume":"5","author":"Pearl","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib30","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1600-6143.2009.02710.x","article-title":"BAFF is increased in renal transplant patients following treatment with alemtuzumab","volume":"9","author":"Bloom","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib31","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.1203261","article-title":"In kidney transplant patients, alemtuzumab but not basiliximab\/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development","volume":"191","author":"Todeschini","year":"2013","journal-title":"J Immunol"},{"key":"10.1111\/ajt.13347_bib32","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1034\/j.1600-6143.2003.00120.x","article-title":"Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study","volume":"3","author":"Knechtle","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1681\/ASN.2014040378","article-title":"Through a glass darkly: Seeking clarity in preventing late kidney transplant failure","volume":"26","author":"Stegall","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13347_bib35","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-6143.2009.02938.x","article-title":"Cluster analysis of lesions in nonselected kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation and scarring","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib37","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1600-6143.2005.01050.x","article-title":"Predicting subsequent decline in kidney allograft function from early surveillance biopsies","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/TP.0000000000000310","article-title":"Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy","volume":"99","author":"Lesage","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13347_bib39","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib40","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/j.1600-6143.2010.03268.x","article-title":"Personal viewpoint: An integrated view of molecular changes, histopathology and outcomes in kidney transplants","volume":"10","author":"Halloran","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0b013e31823bb647","article-title":"Early subclinical rejection as a risk factor for late chronic humoral rejection","volume":"93","author":"Moreso","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13347_bib42","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/ajt.12370","article-title":"Kidney allograft survival after acute rejection, the value of follow-up biopsies","volume":"13","author":"El Ters","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13347_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-6143.2005.01140.x","article-title":"Assessing glomerular filtration rate by estimation equations in kidney transplant recipients","volume":"6","author":"Poggio","year":"2006","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13347","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522004488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522004488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:11:08Z","timestamp":1761628268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522004488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1600613522004488"],"URL":"https:\/\/doi.org\/10.1111\/ajt.13347","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific Antibody","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.13347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}